BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Benktander J, Padra JT, Maynard B, Birchenough G, Botwright NA, McCulloch R, Wynne JW, Sharba S, Sundell K, Sundh H, Lindén SK. Gill Mucus and Gill Mucin O-glycosylation in Healthy and Amebic Gill Disease-Affected Atlantic Salmon. Microorganisms 2020;8:E1871. [PMID: 33256221 DOI: 10.3390/microorganisms8121871] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Talbot A, Mccormack M, Dwivedi A, O'connor I, Valdenegro V, Maccarthy E. Investigation into the potential use of dietary supplementation to reduce the impact of Amoebic Gill Disease. Aquaculture 2022;552:737983. [DOI: 10.1016/j.aquaculture.2022.737983] [Reference Citation Analysis]
2 Aoki K, Kumagai T, Ranzinger R, Bergmann C, Camus A, Tiemeyer M. Serum N-Glycome Diversity in Teleost and Chondrostrean Fishes. Front Mol Biosci 2021;8:778383. [PMID: 34859056 DOI: 10.3389/fmolb.2021.778383] [Reference Citation Analysis]
3 Botwright NA, Mohamed AR, Slinger J, Lima PC, Wynne JW. Host-Parasite Interaction of Atlantic salmon (Salmo salar) and the Ectoparasite Neoparamoeba perurans in Amoebic Gill Disease. Front Immunol 2021;12:672700. [PMID: 34135900 DOI: 10.3389/fimmu.2021.672700] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Hudson J, Nowak BF. Experimental Challenge Models and In Vitro Models to Investigate Efficacy of Treatments and Vaccines against Amoebic Gill Disease. Microorganisms 2021;9:710. [PMID: 33808191 DOI: 10.3390/microorganisms9040710] [Reference Citation Analysis]
5 Sharba S, Sundh H, Sundell K, Benktander J, Santos L, Birchenough G, Lindén SK. Rainbow trout gastrointestinal mucus, mucin production, mucin glycosylation and response to lipopolysaccharide. Fish & Shellfish Immunology 2022. [DOI: 10.1016/j.fsi.2022.01.031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]